Universe Pharmaceuticals Inc balance sheet

At the end of fiscal 2025, Universe Pharmaceuticals Inc had total assets of $69.30bn, total liabilities of $13.17bn and shareholders' equity of $56.13bn. It held $33.59bn in cash against $9.26bn of debt: net cash of $24.34bn.

Balance sheet

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Universe Pharmaceuticals Inc: balance sheet, annual
Fiscal year	2019Sept 2019	2020Sept 2020	2021Sept 2021	2022Sept 2022	2023Sept 2023	2024Sept 2024	2025Sept 2025
Cash and equivalents	0.0	0.0	0.0	5.7	5.3	29.5	33.6
Receivables	—	0.0	0.0	0.0	0.0	12.9	13.0
Inventory	—	0.0	0.0	0.0	0.0	1.7	2.2
Total current assets	—	0.0	0.1	0.0	0.0	51.6	53.6
Total assets	—	0.0	0.1	0.1	0.0	68.0	69.3
Accounts payable	—	0.0	0.0	0.0	0.0	4.9	1.7
Deferred revenue (current)	—	—	—	—	—	—	0.0
Total current liabilities	—	0.0	0.0	0.0	0.0	20.3	13.2
Short-term debt	—	0.0	0.0	0.0	0.0	5.9	2.1
Total debt	0.0	0.0	0.0	0.0	0.0	5.9	9.3
Total liabilities	—	—	—	—	0.0	22.5	13.2
Shareholders' equity	0.0	0.0	0.0	35.3	28.0	45.5	56.1
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	−27.9	—	—
Net debt (negative = net cash)	−0.0	−0.0	−0.0	−5.7	−5.3	−23.6	−24.3
Shares outstanding	—	—	—	—	6m	—	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: UPC vs VTRS HLN vs UPC BHC vs UPC

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Universe Pharmaceuticals Inc's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Universe Pharmaceuticals Inc.